Purpose: Chronic inflammation is involved in retinitis pigmentosa (RP). We demonstrated previously that intraocular inflammatory levels, as measured by slit-lamp ophthalmoscopy or laser flare photometry, are inversely correlated with central visual function in patients with RP. Here, we investigated the relationship between serum high-sensitivity C-reactive protein (hs-CRP) and visual parameters in RP. Methods: We studied 58 consecutive typical patients with RP <40 years old and 29 age-and gender-matched controls. High-sensitivity C-reactive protein (hs-CRP) was detected by immunoturbidimetry. The relationships between hs-CRP and visual parameters including best-corrected visual acuity (BCVA), mean deviation (MD) of static perimetry tests (Humphrey Field Analyzer, the central 10-2 programme) and VA changes over the prior 5 years and MD changes over the prior 3 years were analysed in the patients with RP. Results: The serum hs-CRP levels of the patients with RP were significantly higher than those of the controls (0.06 AE 0.08 versus 0.03 AE 0.04 mg/dl, p = 0.0119). In the patients with RP, there was no correlation of hs-CRP with cross-sectionally assessed VA or MD, but the baseline hs-CRP was significantly correlated with the MD deterioration (r = À0.4073, p = 0.0314). Conclusion: The average serum hs-CRP was significantly increased in the patients with RP, and higher hs-CRP was associated with faster deterioration of central visual function. These results suggest that the systemic inflammatory profile is altered and may be associated with disease progression in RP.
Introduction
Retinitis pigmentosa (RP) refers to a group of intractable, inherited retinal degeneration disorders that affect more than 1.5 million individuals globally (Hartong et al. 2006) . Mutations in more than 50 different genes associated with RP have been identified in genetic studies (RetNet TM , Retinal Information Network. Available at: https://sph. uth.edu/Retnet/). Although the clinical course and progression of RP vary among patients, there are shared clinical characteristics such as night blindness and visual field constriction, due to rod cell loss and the subsequent cone photoreceptor cell loss. Despite advances in our understanding of the genetic background of RP, the biological mechanisms by which the genetic mutations induce photoreceptor cell death have not been fully elucidated (Wright et al. 2010 ). In addition, there is no clinically useful biomarker that predicts the progression of RP.
Cell death and inflammation are closely interactive processes, and neuroinflammation as a critical component in the progression of various neurodegenerative diseases has been studied (Ransohoff & Cardona 2010) . We demonstrated that pro-inflammatory cytokines are substantially increased in the aqueous humour and the vitreous of patients with RP (Yoshida et al. 2013a) . In addition, a higher level of ocular inflammation, as measured by slit-lamp ophthalmoscopy or laser flare photometry, correlates with worse visual function in patients with RP (Yoshida et al. 2013a; Murakami et al. 2015) , supporting the interaction between photoreceptor cell death and intraocular inflammation.
Consistent with these findings, experimental studies showed that inflammatory cell activation occurs at the onset or an early phase of retinal degeneration (Zeng et al. 2005; Yoshida et al. 2013b) and that this activation contributed to rod and cone photoreceptor cell death in animal models of RP (Peng et al. 2014; Zhao et al. 2015) . Notably, using a bone marrow transplantation approach in a mouse model of RP, it was shown that retinal inflammatory microglial cells were recruited from peripheral blood cells, suggesting that the peripheral blood environment may be altered during retinal degeneration in RP (Sasahara et al. 2008) .
High-sensitivity C-reactive protein (hs-CRP) is an inflammatory marker known to be associated with the development of cardiovascular diseases (Sesso et al. 2003; Danesh et al. 2004) . Elevated serum hs-CRP was shown to be associated with various ocular conditions such as age-related macular degeneration (AMD), diabetic retinopathy (DR), uveitis and pathological myopia (Seddon et al. 2004; Hong et al. 2011; Sahin et al. 2012; Laursen et al. 2013; Long et al. 2013 ). The alteration of serum hs-CRP in RP has not been addressed. To investigate the possible role of systemic inflammatory response in RP, we evaluated the changes of serum hs-CRP and their association with visual parameters in patients with RP.
Patients and Methods

Ethics statement
This clinical study was approved by the Institutional Review Board of Kyushu University Hospital (Fukuoka, Japan) and was conducted in accord with the tenets of the Declaration of Helsinki on biomedical research involving human subjects. Written informed consent was obtained from all subjects after a thorough explanation of the nature of the study and its possible consequences.
Participants
Because serum hs-CRP values are influenced by systemic disorders such as cardiovascular diseases, hypertension and diabetes (Sesso et al. 2003; Danesh et al. 2004; Devaraj et al. 2006) , we included systemically healthy and relatively young patients with RP <40 years old. Patients with RP were consecutively recruited from the Kyushu University Hospital in 2014 and 2015, and the blood samples were collected. Fifty-eight patients with the diagnosis of typical RP and 29 age-and gender-matched healthy control subjects were included. The baseline characteristics of all subjects are shown in Table 1 . The examination results of the right eye of each subject were used for analysis. The BCVA and the MD of static perimetry tests (Humphrey Field Analyzer, the central 10-2 programme) were measured on the same day of the blood collection.
The VA changes over the prior 5 years and the MD changes over the prior 3 years were obtained from the retrospective chart review. Visual acuity (VA) tests were performed 9.1 AE 2.8 times (range 5-16 times) during the prior 5 years and MD values were measured 3.8 AE 0.6 times (range: 3-5) during the prior 3 years. The changes of VA and MD were calculated by simply subtracting the values obtained 5 and 3 years ago, respectively, from those on the day of the blood collection.
The diagnosis of typical RP was based on the patient's history of night blindness, visual field constriction and/ or ring scotoma, and markedly reduced or non-recordable a-and b-wave amplitudes on electroretinography testing, in addition to ophthalmoscopic findings (e.g. bone spicule-like pigment clumping in the mid-peripheral and peripheral retina and attenuation of retinal vessels).
Patients with cone-rod or cone dystrophy, Bietti crystalline retinopathy, uveitis or systemic diseases such as hypertension, diabetic mellitus and autoimmune disease and who were regularly taking medications such as antiinflammatory drugs, statins and hormone replacement therapy were excluded from the study, as were subjects with suspected infection or a fever.
All of the control subjects underwent a health screening including examinations of their vision, hearing, height, weight and blood pressure, a urinary strip test, a chest X-ray and a physician examination within the past 1 year, and had results without specific abnormal findings. Subjects who had a history of ocular or systemic disease (e.g. uveitis, hypertension, diabetic mellitus and autoimmune diseases), those who were regularly taking medications (e.g. anti-inflammatory drugs, statins and hormone replacement therapy) and those with suspected infection or fever were excluded.
Clinical examinations
The BCVA was measured with the Landolt decimal VA chart (CV-6000, Tomey, Nagoya, Japan; or AVC-36, Kowa, Nagoya Japan) at 5 m or single Landolt test cards (HP-1258, Handaya, Tokyo, Japan), and the values were converted to the logarithm of the minimum angle of resolution (log-MAR) units. The refractive error was corrected at each visit using multiples lenses with different dioptres to confirm that the VA was best-corrected. The VA was based on the minimum Landolt C letter that the subject was able to correctly answer more than 60% (3/ 5) of the time. The same examination room was used for the VA tests.
Automated static perimetry tests were performed with a Humphrey Field Analyzer (HFA; Humphrey Instruments, San Leandro, CA, USA) Inheritance mode (n) AD 11 AR 9 X-linked 0 Spontaneous 38 AD = autosomal dominant; AR = autosomal recessive; hs-CRP = high-sensitivity C-reactive protein; dB = decibel; logMAR = logarithm of the minimum angle of resolution; MD = mean deviation; VA = visual acuity. * Data are mean AE SD. Ocular characteristics are derived from the right eyes. † n = 56.
using the central 10-2 Swedish Interactive Thresholding Algorithm Standard Program. The lens was corrected as appropriate for the test distance. Visual field testing was repeated if the test reliability was not satisfactory (i.e. fixation loss >20%, false positive >15% or false negative >33%). The test was performed twice in the initial visual field testing, and the result with the better MD value was used for the analysis to reduce the learning effect. A follow-up examination was performed only once unless the test reliability did not meet the criteria.
Blood testing
There was one patient in whom it was not possible to obtain a serum sample because the patient declined it. Eight millilitres of venous blood samples were obtained from an antecubital vein of each subject using the collection tube SIM-L1008SQ3 (Kyokuto Pharmaceutical Industrial Co., Tokyo, Japan) at the same visit as the visual testing. The blood was collected after the vision testing. The serum was subjected to an hs-CRP analysis by latex-enhanced immunoturbidimetry (H7600-310S; Hitachi, Tokyo, Japan).
The hs-CRP measurement in our laboratory has the linear measurement range of 0.01-30.28 mg/dl. The reproducibility was assessed in three different standard samples, and the coefficient variation values of the intraday and interday assays were 0.6-0.8% and 1.7-2.2%, respectively.
Statistical analysis
The data are presented as the arithmetic mean AE standard deviation (SD). Statistical differences in the mean values between the groups were analysed by Wilcoxon rank sum test, and the differences of frequency were tested by chi-square tests. We performed a multiple group comparison by an analysis of variance (ANOVA) followed by Dunnett's adjustment. The relationship between hs-CRP and visual parameters was examined using Spearman's rank correlation coefficient. All of the statistical analyses were performed with SAS software (ver. 9.3, SAS Institute, Cary, NC, USA). Two-sided values of p < 0.05 were considered significant.
Results
Increased serum hs-CRP levels in the patients with RP
The demographic data of the study population are summarized in Table 1 . There were no significant differences in age or gender distribution between the groups. The serum hs-CRP values were significantly increased in the patients with RP (0.06 AE 0.08 mg/dl) compared to those of the control subjects (0.03 AE 0.04 mg/dl, p = 0.0119; Fig. 1 ). To evaluate the hs-CRP changes in early stages of RP, we performed the subgroup analysis of patients with RP whose VA was 20/20 or better. There was a trend, although not statistically significant, for higher CRP levels in RP patients with VA ≥20/20 compared with the control subjects (p = 0.0661, Table 2 ).
We also compared the CRP levels according to the inheritance mode for the patients with RP (Table 3) . Sporadic cases were grouped together with the AR cases, because most of the mutations of sporadic cases are thought to be recessive. The AR and sporadic patients with RP, who had experienced faster deterioration of VA and MD than the AD group, showed higher CRP levels on average, which was a significant difference compared to control subjects (p = 0.0126).
Association between hs-CRP and visual parameters in the patients with RP
We next investigated the correlations between hs-CRP values and visual parameters in the 58 patients with RP. The results of the right eye of each patient were analysed. One patient had received cataract surgery, and the VA and MD data before surgery were not included for the analysis. There were four RP patients associated with cystoid macular oedema, but no patients demonstrated a marked visual improvement with treatment.
As shown in Fig. 2 and Table 4 , Spearman's rank testing showed that there was no significant correlation between hs-CRP and visual acuity (VA; r = 0.0521, p = 0.6975, n = 58) or between hs-CRP and the MD values in the HFA10-2 tests (r = À0.1285, p = 0.3452, n = 56). The serum hs-CRP levels were significantly correlated AD = autosomal dominant; AR = autosomal recessive; hs-CRP = high-sensitivity C-reactive protein; dB = decibel; logMAR = logarithm of the minimum angle of resolution; MD = mean deviation; VA = visual acuity. * Data are mean AE SD. Ocular characteristics are derived from the right eyes.
with the MD deterioration over the prior 3 years (DMD; r = À0.4073, p = 0.0314, n = 27), but not with the VA changes over the prior 5 years (DVA; r = 0.2227, p = 0.1853, n = 36). We performed a sensitivity analysis by removing the individual with MD loss of À4.9 dB from the study. The correlation between hs-CRP and the MD deterioration over the prior 3 years (DMD) showed a trend but not statistical significance (r = À0.3724, p = 0.0610).
Discussion
The serum hs-CRP values of the patients with RP in the present study were significantly increased, and the higher hs-CRP levels were correlated with faster deterioration of central visual function. Together with our previous findings of the association between intraocular inflammation and visual function in RP (Yoshida et al. 2013a; Murakami et al. 2015) , these results indicate that systemic as well as local inflammation is implicated in the pathology of RP, especially in cone degeneration subsequent to rod cell death.
The association between hs-CRP and AMD has been investigated in several studies, but inconsistent results were obtained (Seddon et al. 2004; Dasch et al. 2005) . A meta-analysis of 41 690 participants showed a significant correlation between high serum hs-CRP and late choroidal neovascularization (CNV; Hong et al. 2011) , supporting a role for chronic inflammation in AMD. Hong et al. (2011) reported that subjects with higher hs-CRP (>0.3 mg/dl) had a twofold likelihood of late AMD compared to those with lower hs-CRP (<0.1 mg/dl). However, there are concerns that the measured hs-CRP levels could be affected by various systemic factors such as smoking and atherosclerosis (Yasojima et al. 2001; O'Loughlin et al. 2008) , which are also known as risk factors of AMD, and these confounding factors may have led to the inconsistency of the results.
To minimize the influence of systemic conditions such as lifestyle-related diseases, our present investigation included relatively young (<40-year-old) and otherwise healthy patients with RP. We DMD value/3y (dB) À1.0 AE 1.6 † À1.5 AE 2.6 ¶ AD = autosomal dominant; AR = autosomal recessive; hs-CRP = high-sensitivity C-reactive protein; dB = decibel; logMAR = logarithm of the minimum angle of resolution; MD = mean deviation; VA = visual acuity. * Data are mean AE SD. Ocular characteristics are derived from the right eyes. † n = 7. ‡ n = 29. § n = 45.
-n = 20. hs-CRP = high-sensitivity C-reactive protein; dB = decibel; logMAR = logarithm of the minimum angle of resolution; MD = mean deviation; VA = visual acuity. * n = 58. † n = 36. ‡ n = 56. § n = 27.
showed that the averaged serum hs-CRP values were 0.06 AE 0.08 mg/dl in the patients with RP and 0.03 AE 0.04 mg/dl in the age-matched control subjects. In our laboratory, the linear measurement range for hs-CRP is 0.01-30.28 mg/dl with high reproducibility. Although the hs-CRP values in the present patients with RP were within normal range (<0.1 mg/dl), the subtle but significant changes would be understandable given the small size of the eye. In addition, the subgroup analysis according to the inheritance mode demonstrated that the autosomal recessive cases had higher hs-CRP levels on average. These results are reasonable because recessive mutations often tend to exhibit early onset and severe clinical phenotypes (Gregory-Evans et al. 2013).
Our present findings also demonstrated an association between hs-CRP and the MD deterioration in patients with RP. However, it should be noted that there were large variations of hs-CRP values. We performed a receiver operating characteristic analysis to address the sensitivity and specificity of hs-CRP in a disease versus nondisease comparison, and found a low area under the curve (AUC) value, that is 0.685 (data not shown). These findings suggest that hs-CRP may not be sufficient as a biomarker for RP-especially in uncontrolled clinical settings, in which several systemic factors can influence the serum hs-CRP values.
Our previous studies showed that the extent of inflammation in the anterior vitreous and the aqueous flare values were significantly associated with aspects of central visual function such as VA and MD in patients with RP (Yoshida et al. 2013a; : Murakami et al. 2015) . In contrast, there was no correlation between the serum hs-CRP values and visual function, although the high hs-CRP levels were associated with vision deterioration over the past years. There might be several reasons that explain this discrepancy. A major difference between our present and previous studies is the sample size (58 patients with RP in the present study versus over 150 patients in the previous studies). We excluded patients with RP ≥40 years old to minimize the effect of systemic diseases, and thus, the reduced sample size would attenuate the statistical power in the present study.
In addition, because the younger population often retains good central vision, the vision deterioration rather than visual function itself may better reflect the disease activity for these patients. We also cannot exclude the possibility that the serum hs-CRP could be affected by other systemic factors such as lifestyle and smoking, and these confounding factors may reduce the statistical correlation between hs-CRP and visual function.
Intraocular inflammation in RP is generally thought to be an event that is secondary to rod photoreceptor cell death; however, an accumulating body of experimental evidence suggests that inflammatory cells promote retinal degeneration by their cytotoxic effect on bystander cells such as photoreceptor cells (Peng et al. 2014; Zhao et al. 2015) . Because it is difficult to discriminate the cause-effect relationship in observational studies, the role of inflammation in RP warrants further investigation.
C-reactive protein (CRP) is a pentameric protein that is produced in response to interleukin (IL)-6 as well as other pro-inflammatory cytokines such as IL-1 and tumour necrosis factor-alpha (TNF-a; Jialal et al. 2004 ). Although it is well known that CRP is synthesized in the liver, recent studies have shown that it is also produced in inflammatory sites of various organs including neuronal tissue (Yasojima et al. 2000 (Yasojima et al. , 2001 . The intraocular expression levels of IL-6, IL-1, and TNF-a are substantially increased in patients with RP (Yoshida et al. 2013a) , and these cytokines may increase the CRP production from the retina or other organs. It will be interesting to investigate whether intraocular CRP is elevated in patients with RP and whether it correlates with the serum CRP levels. We were unable to address this question in the present study because there are limited opportunities to obtain aqueous humour or vitreous from younger patients with RP.
Oxidative stress has also been shown to substantially contribute to rod and cone degeneration in animal models of RP (Komeima et al. 2006; Xiong et al. 2015; Nakatake et al. 2016) . Clinical studies demonstrated an increase in oxidized molecules and a decrease in antioxidant proteins/activities in patients with RP (Martinez-Fernandez de la Camara et al. 2013; Campochiaro et al. 2015) , suggesting that findings in animal models may have clinical relevance. However, the serum alteration of the oxidative stress-related factors exhibited conflicting results: Campochiaro et al. (2015) showed no significant difference in protein carbonyl content, oxidized glutathione ratio or superoxide dismutase 3 (SOD3) in the serum of 8-9 RP and seven control subjects, whereas Martı-nez-Fernandez de la Camara et al. (2013) reported that the expression levels of several oxidative and antioxidative markers such as nitrotyrosine, SOD3 and haem oxygenase 1 were altered among 56 patients with RP and 60 control subjects.
This discrepancy could be due to the differences in sample size, study populations and measurement methods, as well as oxidative modification during storage. As reactive oxidative species (ROS) have very short half-lives, ROS produced in the eye may have limited effects on the molecules in the organ systems. In contrast, inflammation has been shown to involve systemic (i.e. bone marrow and peripheral blood) responses in animal models of RP (Sasahara et al. 2008 ). Further comprehensive studies investigating the association between ocular and serum changes in inflammation-and oxidation-related factors and their relationships to visual function may provide important clues to elucidate the involvement of systemic factors in the pathology of RP, and they may lead to the development of biomarkers for RP.
The limitations of our study include its small sample size at a single centre. The criteria of age to minimize the systemic effect on CRP resulted in a reduced sample size. A multicentre study with a larger sample is required to confirm the results of our present analyses.
Another study limitation is the lack of information regarding the genetic backgrounds of the patients with RP. The mechanisms of rod photoreceptor cell death would be variable among causative genes and mutation types. Nevertheless, inflammation underlies various conditions of RP irrespective of its aetiology (Karlstetter et al. 2015) . Therefore, taking the results of present study together with previous findings, we propose that inflammation-related factors such as hs-CRP may be altered as a common pathology of RP.
Thirdly, hs-CRP measurements were made at only one time point for each subject. Therefore, the fluctuation of hs-CRP in patients with RP could not be addressed in the present study. It would be important to test the consistency and stability of hs-CRP values over a short period of time; however, as patients with RP usually visit our hospital once or twice a year, we were not able to answer this question. The longitudinal changes of hs-CRP and their association with the disease process in individual patients should be investigated in further studies.
In conclusion, our results demonstrated that increased serum hs-CRP levels are correlated with a faster progression of central vision loss in patients with RP. These findings may provide clinical evidence of an association between inflammation and retinal degeneration, and they suggest that the alteration of the systemic inflammatory response may be associated with the disease progression of RP.
